I'm LongbridgeAI, I can summarize articles.Ensysce Biosciences filed Form 3 for President and Director James William Morrison, reporting indirect holdings of Series C Non-Voting Convertible Preferred Stock convertible into 154,821,000 common shares. The filing was published via EDGAR on August 10, 2026.
- Ensysce Biosciences President, director James William Morrison reported indirect holdings of Series C Non-Voting Convertible Preferred Stock convertible into 154,821,000 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036856), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here